. Studies in women indicate a stimulat¬ ing effect of exogenously administered estrogens on vasopressin release in postmenopausal subjects (4) ; furthermore, in normally menstruating women the circulating concentrations of vaso¬ pressin rise at the time of ovulation and decrease at the onset of menstruation (5) .
In view of these observations, we wondered whether the regulation of vasopressin secretion was altered in women with polycystic ovaries (PCO), a syndrome characterized by abnormal blood circulating concentrations of sex steroids (6) . For this purpose, the AVP responses to os¬ motic, orthostatic and hypoglycémie stimuli (7) were tested in women with PCO. This protocol was chosen in order to have a wide evaluation of AVP secretion, because stimuli acting through osmoregulation, baroregulation and neuroglucopenia ap¬ pear to increase AVP secretion through independ¬ ent mechanisms and are considered primary ated basal insulin concentrations are a common finding in patients with PCO and have been re¬ lated to hyperandrogenism (8, 9) . In fact, hyperandrogenism is thought to influence hepatic removal of insulin (10) and peripheral insulin sensitivity (8) (9) (10) , without modifying pancreatic insulin se¬ cretion ( 10) . In a previous study, we found low AVP responses to insulin induced hypoglycemia in obese patients with blood concentrations of in¬ sulin higher than normal (11) 
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The basal glucose concentrations and the in¬ cremental pattern after oral glucose ingestion were similar in normal subjects and women with PCO ( Fig. 1 left side) . On the other hand, the basal insulin levels were significantly higher in women with PCO (143.6 ± 10.0 mean ± sem pmol/1) than in normal controls (80.4 ± 3.6; p<0.01). Further¬ more, the insulin response during OGTT was sig¬ nificantly higher in patients with PCO than in con¬ trol subjects (F = 91.95; p< 0.001) (Fig. 1 right   side 4 . Effect of insulin-induced hypoglycemia on GH (upper part) and cortisol (lower part) levels of control (N = 9) and PCO (N = 10) women. Each point represents the mean ± sem of the observations. perimental group. A similar AVP response was ob¬ served in normal women and in patients with PCO (F = 0.78, NS) (Fig. 2) .
Insulin tolerance test Administration of insulin induced a similar de¬ crease in blood glucose concentrations of both normal controls and women with PCO (Fig. 3) . In both groups, AVP rose sharply in response to hypo¬ glycemia, with a mean peak response at the time of the glycémie nadir. However, the AVP response was significantly lower in women with PCO than in normal controls (F = 14.30; p< 0.001). The mean AVP peak was 171 % higher than basal value in con¬ trol subjects, but only 75% higher than baseline in women with PCO.
Basal and hypoglycemia-stimulated GH levels were similar in both groups (Fig. 4 upper part) . Basal cortisol concentrations were higher in women with PCO than in normal controls; how¬ ever, the two groups presented comparable corti¬ sol increments in response to hypoglycemia. In fact, the test of parallelism revealed no significant differences in the cortisol curves between the groups in response to hypoglycemia (Fig. 4 (14) , another condition charac¬ terized by slight insulin resistance (14) .
Cortisol is known to counteract AVP secretion (15) 
